Company news, press releases, and more. Follow this page for new exciting updates and more news on what is happening at CELLINK.
CELLINK Bioprinting AB (CELLINK) has announced a change of leadership with Stefan Blomsterberg taking over as CEO from Cecilia Edebo who will be pursuing another
CELLINK and Ossiform look to capitalize on synergies and bring to the market a highly functional bioink for bone-based research. The partnership has scope for
Gothenburg, October 18th 2023 — CELLINK, a global leader in bioprinting technologies, is proud to announce a pioneering innovation in the field of regenerative medicine
San Diego, USA, October 10th, 2023 – CELLINK, a leading global provider of bioprinting technologies, and the University of California, San Diego (UCSD), a world-renowned
Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK’s bioprinting solutions and Carcinotech’s expertise in producing 3D bioprinted living tumors to
CELLINK, a global leader in 3D bioprinting technologies, is excited to announce a strategic distribution agreement with Paralab, marking a significant expansion of its presence
CELLINK, a global leader in 3D bioprinting technologies, is pleased to announce the signing of a distribution agreement with AXT, a prominent player within the
Gothenburg, Sweden – CELLINK, a global leader in bioprinting, today announced the release of the third generation of their LUMEN X™ product – the new standard
The European-funded PRISM-LT project is set to shape the future of engineered living materials in the European Union. The project aims to develop a versatile
CELLINK and Nanyang Technological University have signed a collaboration agreement where the University’s Singapore Centre for 3D Printing (SC3DP) and CELLINK will jointly open a
Avijit Minocha
Head of Marketing
akm@cellink.com
Send us an email by filling in the contact form here.
U.S.: +1 (833) 235-5465
EU: +46 31-12 87 00
India: +91 (0) 98808 58741
Japan: +81 (75)746-3032
Singapore: +65 8750 2284
